Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 200

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Sialic acid–binding Ig‐like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus

Biesen, Robert, Demir, Cemal, Barkhudarova, Fidan, Grün, Joachim R., Steinbrich‐Zöllner, Marta, Backhaus, Marina, Häupl, Thomas, Rudwaleit, Martin, Riemekasten, Gabriela, Radbruch, Andreas, Hiepe, Falk, Burmester, Gerd‐Rüdiger, Grützkau, Andreas · 2008 · Arthritis & Rheumatism

Abstract

Objective: Type I interferon (IFN) plays a pivotal role in the pathogenesis of systemic lupus erythematosus (SLE) and is therefore considered a potential therapeutic target. This study was undertaken to establish a feasible biomarker for IFN effects with respect to disease activity and effectiveness of IFN‐suppressive therapy in SLE patients. Methods: Transcriptomes of purified monocytes from 9 SLE patients and 7 healthy controls were analyzed by Affymetrix GeneChip technology. Levels of sialic acid–binding Ig‐like lectin 1 (Siglec‐1) (sialoadhesin, CD169) in inflammatory and resident monocytes were determined at the protein level in 38 healthy controls and 52 SLE patients, using multicolor flow cytometry. Results: Transcriptomes of peripheral monocytes from SLE patients revealed a dominant type I IFN signature. Siglec‐1 was identified as one of the most prominent type I IFN–regulated candidate genes. At the protein level, the frequency of Siglec‐1–expressing monocyte subsets was correlated with disease activity (as measured by the SLE Disease Activity Index) and was inversely correlated with levels of complement factors. Most interestingly, levels of anti–double‐stranded DNA (anti‐dsDNA) antibodies were highly correlated with the percentage of resident monocytes, but not inflammatory monocytes, expressing Siglec‐1. High‐dose glucocorticoid treatment resulted in a dramatic reduction of Siglec‐1 expression in cells from patients with active SLE. Conclusion: Our findings indicate that Siglec‐1 expression in resident blood monocytes is a potential biomarker for monitoring disease activity, displaying type I IFN responses, and estimating levels of anti‐dsDNA antibodies. Moreover, our results suggest that resident and inflammatory monocytes contribute differently to the process of autoantibody formation in SLE.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.23404

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

Metadata

Authors
Biesen, R., Demir, C., Barkhudarova, F., Grün, J. R., Steinbrich‐Zöllner, M., Backhaus, M., Häupl, T., Rudwaleit, M., Riemekasten, G., Radbruch, A., Hiepe, F., Burmester, G., & Grützkau, A.
Venue
Arthritis & Rheumatism
Publisher
Wiley
Published
2008-03-27
Volume
58
Issue
4
Pages
1136-1145
ISSN
  • 0004-3591 (ISSN-L)
  • 1529-0131
OpenAlex
W2006194219
Cited by
200
References
1
FWCI
6.07
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.